SCHEMBL3170318

SCHEMBL3170318

CC(=O)NCCNc1cc(NC(=O)CN2CCC(C(C)=O)(c3ccccc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ POLB P06746 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ ADORA1 P30542 8/20 0.40
▸ ADORA3 P0DMS8 8/20 0.40
▸ ADORA2A P29274 6/20 0.40
▸ ADORA2B P29275 3/20 0.40
▸ OPRD1 P41143 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ CLK4 Q9HAZ1 1/20 0.37
▸ HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3165134 0.90 ALDH1A1 (0.48) LMNAMEN1KMT2APOLBADORA1
SCHEMBL3162386 0.87 OPRD1 (0.46) ADORA1ADORA3ADORA2AADORA2BOPRD1
SCHEMBL3164709 0.86 NPC1 (0.47) MEN1KMT2APOLBMAPTADORA1
SCHEMBL3163125 0.86 NPC1 (0.47) MEN1KMT2APOLBMAPTADORA1
SCHEMBL3171920 0.85 ADORA1 (0.47) ADORA1ADORA3ADORA2AADORA2BALDH1A1
SCHEMBL3162879 0.85 UTS2R (0.44) ADORA1ADORA3ADORA2AADORA2B
SCHEMBL3169426 0.85 POLB (0.45) LMNAPOLBADORA1ADORA3ADORA2A
SCHEMBL3163863 0.85 POLB (0.45) LMNAMEN1KMT2APOLBMAPT
SCHEMBL3164858 0.84 ALDH1A1 (0.49) LMNAMAPTADORA1ADORA2AALDH1A1
SCHEMBL3163144 0.84 ADORA3 (0.46) LMNAMEN1KMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback